Search

Author/Creator Smith, C.H.

2. Persistence and effectiveness of nonbiologic systemic therapies for moderate‐to‐severe psoriasis in adults: a systematic review3. (27th March 2019)

Authors:
Mason, K.J.; Williams, S.; Yiu, Z.Z.N.; McElhone, K.; Ashcroft, D.M.; Kleyn, C.E.; Jabbar‐Lopez, Z.K.; Owen, C.M.; Reynolds, N.J.; Smith, C.H.; Wilson, N.; Warren, R.B.; Griffiths, C.E.M.
Journal:
British journal of dermatology
Issue:
Volume 181:Number 2(2019)
Page Start:
256
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (21st October 2018)

Authors:
Yiu, Z.Z.N.; Ashcroft, D.M.; Evans, I.; McElhone, K.; Lunt, M.; Smith, C.H.; Walton, S.; Murphy, R.; Reynolds, N.J.; Ormerod, A.D.; Griffiths, C.E.M.; Warren, R.B.
Journal:
British journal of dermatology
Issue:
Volume 180:Number 2(2019)
Page Start:
329
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗